Department of Experimental and Clinical Medicine, University of Florence, 50137 Florence, Italy.
Cells. 2021 Oct 15;10(10):2759. doi: 10.3390/cells10102759.
Chronic liver injury of different etiologies may result in hepatic fibrosis, a scar formation process consisting in altered deposition of extracellular matrix. Progression of fibrosis can lead to impaired liver architecture and function, resulting in cirrhosis and organ failure. Although fibrosis was previous thought to be an irreversible process, recent evidence convincingly demonstrated resolution of fibrosis in different organs when the cause of injury is removed. In the liver, due to its high regenerative ability, the extent of fibrosis regression and reversion to normal architecture is higher than in other tissues, even in advanced disease. The mechanisms of liver fibrosis resolution can be recapitulated in the following main points: removal of injurious factors causing chronic hepatic damage, elimination, or inactivation of myofibroblasts (through various cell fates, including apoptosis, senescence, and reprogramming), inactivation of inflammatory response and induction of anti-inflammatory/restorative pathways, and degradation of extracellular matrix. In this review, we will discuss the major cellular and molecular mechanisms underlying the regression of fibrosis/cirrhosis and the potential therapeutic approaches aimed at reversing the fibrogenic process.
不同病因引起的慢性肝损伤可导致肝纤维化,这是一种细胞外基质异常沉积的瘢痕形成过程。纤维化的进展可导致肝结构和功能受损,导致肝硬化和器官衰竭。尽管以前认为纤维化是一个不可逆转的过程,但最近的证据令人信服地证明,当损伤的原因消除时,不同器官的纤维化可以得到解决。在肝脏中,由于其高度的再生能力,纤维化的消退和恢复正常结构的程度高于其他组织,即使在疾病晚期也是如此。肝纤维化消退的机制可以概括为以下几点:消除导致慢性肝损伤的有害因素,消除或失活肌成纤维细胞(通过各种细胞命运,包括细胞凋亡、衰老和重编程),抑制炎症反应和诱导抗炎/修复途径,以及细胞外基质的降解。在这篇综述中,我们将讨论纤维化/肝硬化消退的主要细胞和分子机制,以及旨在逆转纤维发生过程的潜在治疗方法。